Advanced Nano-Carriers for Anti-Tumor Drug Loading
Overview
Affiliations
Chemotherapy is one of the important means of tumor therapy. However, most of the anti-tumor drugs that currently used in clinic are hydrophobic non-specific drugs, which seriously affect the efficacy of drugs. With the development of nanotechnology, drug efficacy can be improved by selecting appropriate biodegradable nanocarriers for achieving the controlled release, targeting and higher bioavailability of drugs. This paper reviewed the research progress of anti-tumor drug nanoparticle carriers, which mainly summarized the materials used for anti-tumor drug nanoparticle carriers and their effects in anti-tumor drugs, as well as the targeted drug delivery methods of anti-tumor drugs based on nanocarriers.
A novel process for transcellular hemoglobin transport from macrophages to cancer cells.
Braniewska A, Skorzynski M, Sas Z, Dlugolecka M, Marszalek I, Kurpiel D Cell Commun Signal. 2024; 22(1):570.
PMID: 39605056 PMC: 11603754. DOI: 10.1186/s12964-024-01929-8.
Current status and prospects of MIL-based MOF materials for biomedicine applications.
Lin Z, Liao D, Jiang C, Nezamzadeh-Ejhieh A, Zheng M, Yuan H RSC Med Chem. 2023; 14(10):1914-1933.
PMID: 37859709 PMC: 10583815. DOI: 10.1039/d3md00397c.
Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin's Lymphoma.
Liu S, Xu M, Zhong L, Tong X, Qian S Mini Rev Med Chem. 2023; 24(9):895-907.
PMID: 37724679 DOI: 10.2174/1389557523666230915103121.
Avakh A, Grant G, Cheesman M, Kalkundri T, Hall S Antibiotics (Basel). 2023; 12(8).
PMID: 37627724 PMC: 10451789. DOI: 10.3390/antibiotics12081304.
Smart Polymeric Nanoparticles in Cancer Immunotherapy.
Yu Z, Shen X, Yu H, Tu H, Chittasupho C, Zhao Y Pharmaceutics. 2023; 15(3).
PMID: 36986636 PMC: 10056399. DOI: 10.3390/pharmaceutics15030775.